More than one-third of patients with SSc screened positive for self-reported depression, with GI involvement identified as the most significant predictor.

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

Compared to all-cause acute care and the general population, cannabis-related acute care is associated with a higher 5-year dementia risk.

Topical testosterone therapy does not significantly improve functional outcomes beyond supervised exercise training in older women recovering from a hip fracture.

Following discharge for COVID-19 hospitalization, county-level social deprivation does not affect long-term cardiovascular risk.

Female primary care physicians (PCPs) in value-based payment models have equal or better quality outcomes and higher earning than their male counterparts.

The incidence of early-onset cancers is not rising overall, but rates of certain cancers are increasing among younger patients, new data suggest.

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

The American Academy of Pediatrics presents updated guidance for the treatment of children with atopic dermatitis (AD).

Self-reported cannabis use was not associated with increased postoperative pain in most arthroscopic procedures.

US News & World Report has released its new over-the-counter (OTC) medicine and health product rankings for 2025.

Bimekizumab demonstrated a favorable safety profile for the long-term treatment of axSpA and PsA, with rates of TEAEs remaining stable over time.